Literature DB >> 31693140

Proximal Tubular Vacuolization and Hypersensitivity to Drug-Induced Nephrotoxicity in Male Mice With Decreased Expression of the NADPH-Cytochrome P450 Reductase.

Liang Ding1,2, Lei Li3, Senyan Liu3,4, Xiaochen Bao3, Kathleen G Dickman5, Stewart S Sell3,6, Changlin Mei4, Qing-Yu Zhang1,3,6, Jun Gu3,6, Xinxin Ding1,2.   

Abstract

The effect of variations in the expression of cytochrome P450 reductase (CPR or POR) is determined in mice with decreased POR expression to identify potential vulnerabilities in people with low POR expression. There is an age-dependent appearance of increasing vacuolization in the proximal tubules of the renal cortex in 4- to 9-month-old male (but not female) Cpr-low (CL) mice. These mice have low POR expression in all cells of the body and upregulation of lysosome-associated membrane protein 1 expression in the renal cortex. Vacuolization is also seen in extrahepatic CL and extrarenal CL male mice, but not in mice with tissue-specific Por deletion in liver, intestinal epithelium, or kidney. The occurrence of vacuolization is accompanied by increases in serum blood-urea-nitrogen levels. Male CL mice are hypersensitive to cisplatin- and gentamicin-induced renal toxicity at 3 months of age, before proximal tubular (PT) vacuoles are detectable. At doses that do not cause renal toxicity in wild-type mice, both drugs cause substantial increases in serum blood-urea-nitrogen levels and PT vacuolization in male but not female CL mice. The hypersensitivity to drug-induced renal toxicity is accompanied by increases in circulating drug levels. These novel findings demonstrate deficiency of renal function in mice with globally reduced POR expression and suggest that low POR expression may be a risk factor for drug-induced nephrotoxicity in humans.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cytochrome P450 reductase; drug toxicity; kidney injury; nephrotoxicity; proximal tubules; vacuolization

Mesh:

Substances:

Year:  2020        PMID: 31693140      PMCID: PMC8000068          DOI: 10.1093/toxsci/kfz225

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  55 in total

1.  A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies.

Authors:  Neeraja Kambham; Suja Nagarajan; Sheryl Shah; Li Li; Oscar Salvatierra; Minnie M Sarwal
Journal:  Clin J Am Soc Nephrol       Date:  2006-11-08       Impact factor: 8.237

Review 2.  Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity.

Authors:  Júlia Coelho França Quintanilha; Vanessa Marcilio de Sousa; Marília Berlofa Visacri; Laís Sampaio Amaral; Roseane Maria Maia Santos; Tomás Zambrano; Luis Antonio Salazar; Patricia Moriel
Journal:  Cancer Chemother Pharmacol       Date:  2017-06-13       Impact factor: 3.333

Review 3.  Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update.

Authors:  Neife Aparecida Guinaim dos Santos; Maria Augusta Carvalho Rodrigues; Nadia Maria Martins; Antonio Cardozo dos Santos
Journal:  Arch Toxicol       Date:  2012-03-01       Impact factor: 5.153

Review 4.  P-450 cytochromes: structure and function.

Authors:  S D Black; M J Coon
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1987

5.  Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism.

Authors:  Steven N Hart; Shuang Wang; Kaori Nakamoto; Christopher Wesselman; Ye Li; Xiao-bo Zhong
Journal:  Pharmacogenet Genomics       Date:  2008-01       Impact factor: 2.089

6.  Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.

Authors:  Jun Gu; Yan Weng; Qing-Yu Zhang; Huadong Cui; Melissa Behr; Lin Wu; Weizhu Yang; Li Zhang; Xinxin Ding
Journal:  J Biol Chem       Date:  2003-04-15       Impact factor: 5.157

7.  Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine.

Authors:  Qing-Yu Zhang; Laurence S Kaminsky; Deborah Dunbar; Jin Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2007-06-13       Impact factor: 3.922

8.  Gender differences in predictors of the decline of renal function in the general population.

Authors:  Nynke Halbesma; Auke H Brantsma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E De Jong; Ronald T Gansevoort
Journal:  Kidney Int       Date:  2008-05-21       Impact factor: 10.612

9.  Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule.

Authors:  E I Christensen; A B Maunsbach
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

10.  NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology.

Authors:  David S Riddick; Xinxin Ding; C Roland Wolf; Todd D Porter; Amit V Pandey; Qing-Yu Zhang; Jun Gu; Robert D Finn; Sebastien Ronseaux; Lesley A McLaughlin; Colin J Henderson; Ling Zou; Christa E Flück
Journal:  Drug Metab Dispos       Date:  2012-10-19       Impact factor: 3.922

View more
  3 in total

1.  INTEDE: interactome of drug-metabolizing enzymes.

Authors:  Jiayi Yin; Fengcheng Li; Ying Zhou; Minjie Mou; Yinjing Lu; Kangli Chen; Jia Xue; Yongchao Luo; Jianbo Fu; Xu He; Jianqing Gao; Su Zeng; Lushan Yu; Feng Zhu
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

2.  Experimental malaria-associated acute kidney injury is independent of parasite sequestration and resolves upon antimalarial treatment.

Authors:  Hendrik Possemiers; Emilie Pollenus; Fran Prenen; Sofie Knoops; Priyanka Koshy; Philippe E Van den Steen
Journal:  Front Cell Infect Microbiol       Date:  2022-08-08       Impact factor: 6.073

Review 3.  Sex Difference in Cisplatin-Induced Nephrotoxicity: Laboratory and Clinical Findings.

Authors:  Fatemeh Eshraghi-Jazi; Mehdi Nematbakhsh
Journal:  J Toxicol       Date:  2022-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.